2022
DOI: 10.1007/s10096-022-04428-1
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating outcomes associated with revised fluoroquinolone breakpoints for Enterobacterales urinary tract infections: A retrospective cohort study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…However, this study did not include information about the class of antibiotic used for the comparisons. Studies conducted with quinolones have shown that inappropriate therapy may affect the efficacy of these antimicrobial agents [ 13 , 14 ], with a relative higher risk of recurrence. Our study showed a similar rate of readmission secondary to a relapsing or recurring episode of pyelonephritis, but since this was a retrospective study, an information bias could be responsible for some missing endpoints (i.e., patients that were hospitalized in other hospitals that were not able to be identified as recurrent infection).…”
Section: Discussionmentioning
confidence: 99%
“…However, this study did not include information about the class of antibiotic used for the comparisons. Studies conducted with quinolones have shown that inappropriate therapy may affect the efficacy of these antimicrobial agents [ 13 , 14 ], with a relative higher risk of recurrence. Our study showed a similar rate of readmission secondary to a relapsing or recurring episode of pyelonephritis, but since this was a retrospective study, an information bias could be responsible for some missing endpoints (i.e., patients that were hospitalized in other hospitals that were not able to be identified as recurrent infection).…”
Section: Discussionmentioning
confidence: 99%